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The development of high sensitivity biosensors, for example for clinical diagnostics, requires the
identiﬁcation of suitable receptor molecules which oﬀer high stability, speciﬁcity and aﬃnity, even when
embedded into solid-state biosensor transducers. Here, we present an electrochemical biosensor
employing small synthetic receptor proteins (Mw < 15 kDa) which emulate antibodies but with improved
stability, sensitivity and molecular recognition properties, in particular when immobilized on a solid
sensor surface. The synthetic receptor protein is a non-antibody-based protein scaﬀold with variable
peptide regions inserted to provide the speciﬁc binding, and was designed to bind anti-myc tag antibody
(Mw  150 kDa), as a proof-of-principle exemplar. Both the scaﬀold and the selected receptor protein
were found to have high thermostability with melting temperatures of 101 C and 85 C, respectively.
Furthermore, the secondary structures of the receptor protein were found to be very similar to that of
the original native scaﬀold, despite the insertion of variable peptide loops that create the binding sites. A
label-free electrochemical sensor was fabricated by functionalising a microfabricated gold electrode
with the receptor protein. A change in the phase of the electrochemical impedance was observed when
the biosensor was subjected to anti-myc tag antibodies at concentrations between 6.7 pM and 6.7 nM.
These ﬁndings demonstrate that these non-antibody receptor proteins are excellent candidates for
recognition molecules in label-free biosensors.Introduction
The ability to detect specic biomarkers present in a patient's
blood or other biological samples, even at very low concentra-
tions, make electrochemical biosensors a viable technology for
diagnosis and monitoring. A typical biosensor comprises a
series of receptor molecules immobilized either directly on a
conductive substrate,1,2 or indirectly via a self-assembled
molecular monolayer.3 When the sensor is exposed to a solution
containing the specic biomarker, selective binding of the
biomarker to the immobilized receptors occurs, leading to a
measurable real-time change in an electrical signal within the
sensor.4 The degree of change in the signal provides a measure
of the biomarker concentration and, therefore, an indication of
disease presence and progression.
Among the various receptor molecules used for such
biosensors, native antibodies are the most commonlyectrical Engineering, University of Leeds,
il: c.walti@leeds.ac.uk
, University of Leeds, Woodhouse Lane,
iology, University of Leeds, Woodhouse
tion (ESI) available. See DOI:
hemistry 2015employed as in principle, they are sensitive and selective
towards the target biomarker proteins.5 However, despite
their widespread use, there can be signicant challenges.
Antibodies are large, multi-domain proteins with a number
of disulphide bonds and can therefore be relatively unstable.
They can suﬀer from loss of aﬃnity and specicity upon
immobilization on a solid surface,5,6 non-specic binding to
the other regions of the antibody or the surface,7 steric
hindrance issues, and instability during regeneration of the
functionalized sensor surface.8–10 The bulky multi-meric
nature of the antibodies also makes the interaction with the
target protein unpredictable, in particular on solid
surfaces.11 In addition, antibodies are oen diﬃcult to
produce recombinantly in a bacterial system, and hence their
production can be a time-consuming and expensive
process.12
To address these challenges, smaller recombinant antibody
fragments have been proposed as alternative receptors.12–14
Their small size was found to reduce steric hindrance, increase
surface coverage during immobilization,15 and allow binding to
target epitopes that were generally not accessible to full size
native antibodies.16However, antibody fragments are also prone
to experience a partial loss of their biological activity owing to
change in conformation and/or orientation when immobilized
on solid surfaces, and therefore can show reduced aﬃnity to theAnalyst, 2015, 140, 803–810 | 803
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View Article Onlinetarget molecule.8 In addition, short unconstraint peptides17,18 as
well as nucleic acid aptamers19 have been demonstrated as
biosensor transducers.
As a further alternative to antibodies, small and easy-to-
express non-antibody protein scaﬀolds, designed to constrain
and display variable peptide inserts for target protein recogni-
tion, have also been proposed.20–24 The ambition is to develop a
robust scaﬀold that can be used to develop receptor proteins
that mimic antibodies, but with improved stability and the
surface immobilization properties that are required for
biosensor applications.
Here, we report the use of a small receptor protein (Mw 
15 kDa) based on a non-antibody scaﬀold protein as the target-
specic receptor molecule in a label-free electrochemical
biosensor. Receptor proteins were isolated that bind anti-myc
tag antibody (Mw  150 kDa) as the model target for this proof-
of-principle study. The receptor proteins were characterized in
detail and show high thermostability and reproducible refold-
ing. Furthermore, we show that the secondary structure of the
scaﬀold portion of the receptor protein remains intact upon
insertion of the variable peptides loops.Results and discussion
The employed antibody mimetic scaﬀold provides a robust and
exible alternative to antibodies for developing receptor
proteins with highly specic molecular recognition properties.
It is based on a consensus protein sequence and provides a
structurally highly robust protein able to present one to three
‘variable’ peptides as interaction sites without compromising
the structural integrity of the protein. Design of the variable
peptide regions allowed the creation of a library from which
receptor proteins suitable for highly specic binding to chosen
target molecules can be selected. Here, we demonstrate the
integration of selected receptor proteins into solid state devices
as the molecular recognition element in an electrochemical
biosensor. The model target chosen to demonstrate the concept
was anti-myc tag antibody, because the interaction of this
antibody with the c-myc epitope sequence (EQKLISEEDL) is well
characterized and is widely used to detect over-expressed
recombinant proteins carrying the myc epitope tag.25Generating receptor proteins
Receptor proteins that mimic the c-myc tag were generated via
screening of a phage display library of diversity about 109
generated from library DNA sourced from Sloning BioTech-
nology GmbH (MorphoSys) in which the three variable peptide
regions on the scaﬀold were replaced with randomised peptides
of 6, 9 and 9 amino acids excluding cysteine, respectively. The
library was screened against biotinylated anti-myc tag antibody.
Phage particles displaying receptor proteins with aﬃnity for the
target were eluted aer three rounds of panning by exposure to
higher concentrations of anti-myc tag antibody.
Forty-eight phage clones were arbitrarily selected from the
eluted population. Following amplication, the aﬃnity of the
receptor proteins displayed on these phage particles for binding804 | Analyst, 2015, 140, 803–810to anti-myc tag antibody was determined using a phage ELISA.
About 70% of the selected phage clones showed signicant
binding to anti-myc tag antibody, with almost no binding
observed in the control wells. These data conrm the specicity
of selected receptor proteins expressed on the surface of the
phage particles (Fig. S1 in ESI†).
The twenty receptor proteins with the highest apparent
aﬃnity for anti-myc tag antibody were selected and sequenced.
For all selected receptor proteins, the amino acid sequence of
one of the variable regions was found to resemble the LISE part
of the c-myc epitope sequence (Fig. 1). This region is known to
be the key sequence in facilitating c-myc epitope binding to
anti-myc tag antibody.26 Ten clones with the highest sequence
similarity to the c-myc tag were chosen for further analysis. The
position of relevant sequences in diﬀerent loops of the receptor
proteins, and their similarity to the c-myc epitope sequence
EQKLISEEDL, is also shown in Fig. 1.
The nucleic acid sequences of the ten selected receptor
proteins plus 8-histidine tag were inserted at the multiple-
cloning region of the pET-11(a) bacterial expression vector (see
Fig. S2†). Following transformation into Escherichia coli XL10
Gold cells, colonies were screened for the correct insert by
colony PCR and DNA sequencing.
The protein expression conditions were established for a
receptor protein recognising glutathione S-transferase (GST).
Four diﬀerent expression hosts, BL21 Star (DE3), C41 (DE3), C43
(DE3), and BL21 Gold cells (DE3), were tested in diﬀerent auto-
inductionmedia. Dot blot analysis revealed that BL21 Star (DE3)
cells grown in terric broth (TB) and yeast extract/tryptone (2YT)
showed maximal expression levels (Fig. S3†).
The solubility of the expressed receptor proteins was inves-
tigated by analysing aliquots of supernatant and total cell lysate
on a 15% SDS (sodium-dodecyl-sulfate) polyacrylamide gel fol-
lowed by western blot analysis with HRP-conjugated anti-histi-
dine tag antibody. As expected, a band was detected at 12–15
kDa for both supernatant and total cell lysate (Fig. S4†),
demonstrating that the receptor proteins were expressed
correctly under the optimized conditions.
To identify the receptor protein with the highest aﬃnity for
anti-myc tag antibody an ELISA assay was performed. The
puried receptor proteins at 10 mg ml1 together with an anti-
GST receptor and the native scaﬀold as controls, were immo-
bilized on an ELISA plate which was then exposed to 1 mg ml1
anti-myc tag antibody. Successful binding of the target to the
receptor protein was detected with a 1 : 4000 dilution of anti-
mouse antibody conjugated to HRP followed by colorimetric
detection (Fig. 2). The specicity and cross-reactivity of the
receptor–target binding interaction was investigated using
another mouse antibody (anti-b2 microglobulin antibody) and
BSA (bovine serum albumin) as controls. Identical ELISA plates
to the ones used above were incubated separately with 1 mg ml1
of each control.
Receptor protein-2 and -13 showed highest binding signal
for anti-myc tag antibody, followed by receptor protein-11 and
-7. The responses of the other receptor proteins were of the
same order of magnitude as that of the native scaﬀold
(<0.2 a.u.). A similarly low (<0.2 a.u.) binding response wasThis journal is © The Royal Society of Chemistry 2015
Fig. 1 (a) Sequences of the twenty receptor proteins (1–20) selected from the phage ELISA listed in decreasing order of aﬃnity to anti-myc tag
antibody estimated from the corresponding phage ELISA signals. NTVR (N-terminal variable region), loop-1 and loop-2 represent the three
variable regions where the random amino acid sequences are inserted, with the remaining sequence conserved. (b) Variable regions of the ten
selected receptor proteins showing maximum consensus with the c-myc epitope EQKLISEEDL. The amino acid sequence most closely
resembling LISE is shown in bold.
Fig. 2 Absorbance measured at 650 nm showing the ELISA response
of the ten selected receptor proteins after subjecting them to
monoclonal anti-myc tag antibody, anti-b2 microglobulin antibody
and BSA. ELISA intensities >0.2 a.u. are considered to represent a
positive response. The native scaﬀold and the GST receptor protein
were used as controls, and only minimal response was observed.
This journal is © The Royal Society of Chemistry 2015
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View Article Onlineobserved for all receptor proteins when exposed to the controls
(BSA and anti-b2 microglobulin antibody), demonstrating
specic binding of receptor protein-2, -13, -11 and -7 to the anti-
myc tag antibody. However, receptor protein-13 was found to
aggregate and precipitate readily, which may be attributed to
the presence of the hydrophobic phenylalanine and proline
residues in one of the variable loops and which makes the
receptor protein-13 prone to aggregation.27 The response of
receptor proteins-7 and -11 is only about twice that of the
negative controls, and therefore receptor protein-2 was chosen
as the receptor protein for label-free biosensing and was char-
acterised in detail.Characterization
Aﬃnity. The aﬃnity of receptor protein-2 for monoclonal
anti-myc tag antibody was investigated by bio-layer interfer-
ometry (BLI). Receptor protein-2 was immobilized on a BLI
sensor which was then challenged with diﬀerent concentrations
of anti-myc tag antibody. Aer 600 seconds PBS buﬀer was
reapplied and the dissociation phase was observed (Fig. S5†).
The response of the sensor at equilibrium is shown as aAnalyst, 2015, 140, 803–810 | 805
Fig. 3 (a) Binding response of monoclonal anti-myc tag antibody to receptor protein-2. The solid line shows the ﬁt to the linearized form of the
data. Inset: linearized form of binding data where the y-axis label R/c corresponds to the sensor response (R) divided by anti-myc tag antibody
concentration (c), and the x-axis label to the sensor response (R), respectively. (b) Typical sensogram showing the binding response of
monoclonal anti-myc tag antibody to receptor protein-2, as well as negative controls (response of: BSA to receptor protein-2, monoclonal anti-
myc tag antibody to native scaﬀold, BSA to native scaﬀold).
Fig. 4 CD spectra of the scaﬀold and receptor protein-2, both at a
concentration of 0.5 mg ml1. The two spectra show the same char-
acteristic features indicating the presence of predominantly anti-
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View Article Onlinefunction of concentration in Fig. 3a. The solid line represents a
t of R ¼ cBmax/(c + KD) to the data in linearized form (Scatchard
plot, shown in the inset of the gure), with R the sensor
response at equilibrium, c the anti-myc tag antibody concen-
tration, and Bmax the saturation response. The t reveals an
equilibrium dissociation constant KD of 360  10 nM. We note
that the extracted dissociation constant is higher than the
dissociation constant measured in solution for the c-myc
eptiope,28 which can be expected for a surface-immobilized
binding molecule.
Fig. 3b shows a typical BLI association/dissociation senso-
gram for a receptor protein-2-functionalised surface when
challenged with an anti-myc tag antibody concentration of
130 nM. To demonstrate the specicity of receptor protein-2,
analogous binding curves were obtained for the binding of BSA
to receptor protein-2 and the binding of anti-myc tag antibody
to the native scaﬀold (Fig. 3b). Both show no detectable binding.
Secondary structure. While the scaﬀold proved to be robust,
it is important that variable peptide insertion does not disrupt
the secondary structure of the scaﬀold. The secondary struc-
tures of the scaﬀold as well as receptor protein-2 were analyzed
by circular dichroism (CD) in the far-UV range (180–250 nm) at a
protein concentration of 0.5 mg ml1. The CD spectra (Fig. 4)
show the characteristic signatures of predominantly anti-
parallel b-pleated sheets. A positive peak was observed at 195
nm in both cases followed by a broad featureless minimum at
218 nm, which signies high b-sheet content. There is a
diﬀerence in ellipticity between the receptor protein-2 and the
native scaﬀold protein around 195 nm which is likely owing to
the diﬀerence in amino acid sequence and length at the variable
peptide regions. The variation in ellipticity at 218 nm was only
small, conrming that the predominant anti-parallel b-sheet
structure is conserved between the receptor protein-2 and the
native scaﬀold.
Stability. An important requirement for receptor proteins in
biosensor applications is high stability.29 This improves the
compatibility of the receptor proteins with solid surfaces and806 | Analyst, 2015, 140, 803–810increases shelf life. To investigate the stability of the new
receptor proteins their heat capacity (Cp) was measured as a
function of temperature between 20 C and 110 C using
diﬀerential scanning calorimetry (DSC). Changes in the struc-
ture of the protein, such as unfolding, lead to anomalies in Cp.
The heat capacity vs. temperature for the native scaﬀold and the
receptor protein-2 are shown in Fig. 5. For both proteins, a
distinct peak is observed at 101 C and 85 C, respectively,
indicating the thermal unfolding of the proteins. The very high
melting temperatures (Tm) demonstrate the exceptional
stability of the scaﬀold and receptor protein. The reduced
melting temperature of the receptor protein can be attributed to
the additional amino acids in the variable regions.
In addition, the unfolding of receptor protein-2 was found to
be reversible during repeated thermal scans with no degrada-
tion observed even aer 30 cycles with an identical Tm ¼ 85 C.parallel b-pleated sheets.
This journal is © The Royal Society of Chemistry 2015
Fig. 5 Heat capacity as a function of temperature. (a) Receptor protein-2, showing a melting temperature Tm ¼ 85 C. The diﬀerent colours
correspond to individual sweeps and show the high reversibility of unfolding. Tm remains the same for at least 30 sweeps. (b) Native scaﬀold,
showing Tm ¼ 101 C.
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View Article OnlineHowever, for the native scaﬀold, the thermal cycling was not
reversible, most likely because the temperatures of >100 Cmay
have caused aggregation and inhibited the re-folding of the
scaﬀold.Label-free electrochemical biosensor
The highly stable receptor protein-2 was integrated into a non-
faradaic electrochemical impedance biosensor to demonstrate
the label-free detection of anti-myc tag antibodies. Following
assembly of a monothiol-alkane-PEG-acid (SH–(CH2)11–EG6–
COOH) self-assembled monolayer (SAM) onto a gold substrate,
the receptor protein-2 was immobilized through EDC/NHS
amine coupling chemistry. The COOH was activated by expo-
sure to NHS/EDC for 15 min, and subsequently 500 ml of 10 mg
ml1 receptor protein-2 was deposited onto the surface. This
functionalised gold surface formed the working electrode of the
three-electrode electrochemical sensor, with an Ag/AgCl satu-
rated KCl electrode as the reference electrode, and a platinum
wire as the counter electrode. The electrochemical impedance
was measured over a frequency range from 50 mHz to 100 kHz.
We have shown previously that the shi in the phase of the
electrochemical impedance can be used to monitor binding at
the sensor surface,3 and an increase in phase is expected withFig. 6 (a) Phase-shift of electrochemical impedance, Dq(f), at 0.1 Hz of th
exposed to anti-myc tag antibodies at concentrations between 6.7 pM
15 minutes prior to measurements. (b) Sensor response to diﬀerent conc
0.05 Hz.
This journal is © The Royal Society of Chemistry 2015increasing target concentration. Before challenging the sensor
surface with anti-myc tag antibody, the stability of the sensor
was ascertained by measuring the phase response of the sensor
in 100 mM PB pH 7 aer 5 consecutive buﬀer injections in
intervals of 15 minutes. Fig. 6a shows the last three measure-
ments of the phase of the electrochemical impedance at
100 mHz before the application of diﬀerent concentrations of
anti-myc tag antibody, and only minimal noise (<0.1) was
observed (blue squares in Fig. 6a). The nal measurement was
then taken as the baseline of the sensor.
The sensor was then subjected to diﬀerent concentrations of
the monoclonal anti-myc tag antibody ranging from 6.7 pM to
6.7 nM in 100 mM PB pH 7. The phase of the impedance of the
sensor was measured aer 15 minutes incubation with the
sample. The response of the sensor to diﬀerent concentrations
of anti-myc tag antibody measured at 100 mHz is shown in
Fig. 6a (red circles). A sharp increase in the phase of the
impedance was observed for the lowest concentrations repor-
ted, with a slope of approximately 1.2 per decade. The sensor
response saturated above a concentration of 330 pM, yielding a
dynamic range of around two orders of magnitude.
We note that the change in phase is larger at smaller
frequencies, and for the same concentration of target, the
sensor response is most pronounced at the lowest frequencye biosensor, during initial stabilization checks (blue squares) and when
and 3.3 nM in 100 mM PB buﬀer pH 7. The sensor was incubated for
entrations of anti-myc tag antibodies measured at 0.5 Hz, 0.1 Hz and
Analyst, 2015, 140, 803–810 | 807
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View Article Online(50 mHz). The phase shi as a result of target binding is shown
for diﬀerent frequencies (50 mHz, 100 mHz, and 500 mHz) in
Fig. 6b. However, while the phase shi is largest for 50 mHz, the
instrument error at this frequency is signicantly larger than at
higher frequencies and hence the measurements are less reli-
able. The signal-to-noise ratio was found to be optimal at
around 100 mHz and hence this frequency is used as the sensor
response to quantify the amount of binding on the sensor
surface.
Conclusion
A non-antibody receptor protein that mimics the c-myc epitope
was developed as the capture molecule for a label-free electro-
chemical biosensor. The native scaﬀold and selected receptor
proteins were characterized. The scaﬀold and receptor proteins
were found to be very stable with melting temperatures of 101
C and 85 C for the native scaﬀold and the receptor protein-2,
respectively, and the latter was found to refold aer thermal
denaturation. The secondary structure of the scaﬀold portion of
receptor protein was found to be maintained despite the
insertion of variable peptide sequences and predominantly
b-sheet structures were observed. High melting temperature,
reliable refolding, and robust secondary structures are impor-
tant prerequisites for applications where capture molecules are
employed far from physiological conditions, such as in
biosensors. From BLI experiments, the dissociation constant KD
of the receptor protein–monoclonal anti-myc tag antibody
complex was found to be approximately 360 nM. However, when
the receptor protein was used as the capture molecule in an
electrochemical impedimetric biosensor, where it was immo-
bilised on the sensor surface to measure the concentrations of
anti-myc tag antibodies, concentrations in the range of 6.7 pM
to 330 pM could be measured. These nding demonstrate that
such non-antibody receptor proteins are suited as capture
molecules for label-free detection of biomarkers in solid-state
biosensors.
Materials and methods
Receptor protein selection
A phage display library of approximately 1  109 clones was
generated using a synthetic library construct, containing three
variable peptide regions without cysteines, from Sloning
BioTechnology GmbH (now Morphosys). The library construct
was amplied by Phusion High Fidelity Polymerase (NEB) at 98
C for 5 min then 10 cycles of 98 C, 10 seconds; 56 C, 15
seconds; 72 C, 15 seconds followed by 72 C for 5 minutes
using the forward primer 50-TCTGGCGTTTTCTGCGTC-30 and
reverse primer 50-CTGCGGAACTCCTGCAGTTC-30. The ampli-
ed product was digested with NheI and PstI, gel-extracted and
cloned into the similarly digested pBSTG1-Ad phagemid.
Ligated products were used for electroporation as previously
described.30 Phage display was performed on Maxisorb plates,
which were coated with 50 ml of 1 mg ml1 anti-myc tag antibody
overnight at 4 C and blocked in 2 PBS blocking buﬀer (Sigma
Aldrich, UK) for a minimum of 4 hours at 37 C. Approximately808 | Analyst, 2015, 140, 803–8101012 cfu pre-panned phage were used for a 30 min panning,
wells were washed 30 times and eluted with 50 mM glycine–HCl
(pH 2.2) for 10 min, and neutralised with 1 M Tris-HCl (pH 9.1).
Eluted phage were used to infect ER2738 cells and new phage
were propagated as reported elsewhere.30 A 0.5 ml aliquot of
phage suspension was used for the second round of selection
using 2 ml of Protein A magnetic beads slurry (Invitrogen). Anti-
myc tag antibody immobilized beads were washed and incu-
bated with pre-panned phage for 30 min then washed ve times
and eluted as before. Aer two panning rounds 48 randomly
chosen clones were tested for specicity by phage ELISA on anti
myc tag antibody coated Maxisorb plates. In addition, ELISA
was performed as previously described.30
We identied 34 positive clones (about 70%) by phage ELISA
and determined the sequence of 20 clones of diﬀerent signal
intensities. 19 clones were unique and conrmed the high
complexity of the library. From this selection, the ten clones
with the highest sequence similarity to the c-myc tag were
chosen for further analysis.
The nucleic acid sequences for the selected proteins from the
phage ELISA were then cloned into a modied pET-11(a) vector
via NheI and NotI restriction sites (see Fig. S2†). The ligated
vector was then transformed into competent XL-10 Gold E. coli
cells by a heat shock treatment.31 DNA was isolated from a
number of colonies and the insert sequences were determined
by sequencing (GATC Biotech and Beckmann Coulter
Genomics).Optimization of protein expression
To determine the optimal conditions for recombinant protein
expression, four diﬀerent expression hosts were tested: BL21
Star (DE3); C41 (DE3); C43 (DE3); and, BL21 Gold (DE3). Cells
were grown in diﬀerent autoinduction media: LB (Luria Ber-
tani); TB (Terric broth); SB (Super broth); and, 2YT (Yeast
extract/tryptone) (all sourced from Formedium). The media
contained 30 mg ml1 chloramphenicol and 50 mg ml1 carbe-
nicilin antibiotics. The pET-11(a) expression plasmid carrying
the receptor protein sequence was transformed into each E. coli
strain. A colony was picked and 2 ml of ZYP-0.8 G containing
carbenicilin and chloramphenicol was inoculated in a well of a
24-well plate. The cells were grown at 37 C for 6 hours at 1300
rpm in a plate incubator.32 200 ml samples were then harvested
into a 96-well plate at time intervals of 16, 24, 40, 48, 64, and
72 hours. The collected samples were lysed using lysis buﬀer
(50 mM HEPES, 25% w/v sucrose, 5 mM MgCl2, 1% triton vol/
vol, 10 U/ml omnicleave, 0.1 mg ml1 lysozyme, pH 8) and an
immuno-dot blot assay was performed.33 Lysed cells were dis-
solved in dot blot solubilisation buﬀer (50 mM Tris, NaCl 300
mM, 8 M guanidium chloride, pH 8). The blocking buﬀer con-
sisted of 3% BSA and 1 TBST (Tris buﬀered saline tween-Tris
50 mM, NaCl 150 mM, 0.1% Tween, pH 7.4).
The control comprised various concentrations of histidine-
TEVp (His-tagged tobacco etch virus protease). The positive
samples identied from the dot blot were further investigated
by western blot analysis. The samples were transferred from a
15% SDS PAGE gel (200 V, 1 h) to nitrocellulose membraneThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineusing transfer buﬀer (Tris 0.1 M, glycine 0.192 M, methanol
20%) by applying a constant current of 0.8 mA cm2 for 1 hour.
The immunodetection of the proteins was performed using
1 : 5000 dilution of anti-histidine antibody conjugated to
horseradish peroxidise (HRP) (R&D Systems) and the chemilu-
minescent detection was performed using SuperSignal West
Pico chemiluminescent substrate (Thermo Scientic).
Expression and purication of receptor proteins
The pET-11(a) vector containing anti-myc tag antibody receptor
protein sequences was transformed into BL21 Star (DE3) cells. 2
ml of ZYP-0.8G media was inoculated with a single transformed
bacterial colony and incubated for 6 hours at 37 C. A 400 ml
aliquot was used to inoculate 400 ml of TB auto-induction
medium containing 30 mg ml1 chloramphenicol and 50 mg ml1
carbenicilin. The culture was incubated for 48 hours (37 C, 250
rpm) and the cells were then harvested by centrifugation at
3,000  g for 30 min and frozen at 20 C.
The cell pellet was re-suspended in 50 ml binding buﬀer
(50 mM HEPES, 20 mM NaCl, 5 mM imidazole, pH 7.5), and
sonicated for ve 60 s cycles using a Branson sonicator at 50%
duty cycle. During sonication, the cell-pellet was kept on ice to
avoid over-heating. The sample was then centrifuged in a Sor-
vall centrifuge at 16,000 rpm for 20 minutes at 4 C. 40 ml of the
supernatant was collected and applied with a syringe onto the 1
ml Hitrap column (GE healthcare) pre-equilibrated with 10
column volumes (CVs) of binding buﬀer. The column was then
washed with 10 CVs of binding buﬀer followed by 10 CVs of
wash buﬀer (50 mM HEPES pH 7.5, 200 mM NaCl and 40 mM
imidazole). The proteins were eluted with 10 CVs of elution
buﬀer (50 mM HEPES pH 7.5, 200 mM NaCl and 500 mM
imidazole) and 1 ml fractions were collected in a 96-well plate.
The eluted fractions containing proteins were pooled together
and dialysed against 1 PBS (Phosphate buﬀer saline, 136.8
mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.7 mM KH2PO4)
using a 3.5 kDa molecular weight cut oﬀ dialysis tubing. The
puried proteins were then analysed on a 15% SDS (sodium
dodecyl sulphate) PAGE gel (Fig. S6†). The SDS PAGE was run at
a constant voltage of 120 V with an initial current of approxi-
mately 60 mA for 60 minutes, and stained with Coomassie
brilliant blue.34 The puried receptor proteins migrated at a
position corresponding to 12–15 kDa (Fig. S6†), which is in good
agreement with their calculated theoretical molecular weight of
13–14 kDa. As expected, the native scaﬀold migrated slightly
faster owing to the lower molecular weight (Fig. S6b†).
ELISA
A 96-well plate (Nunc MaxiSorp) was coated with 10 mg ml1 of
receptor protein prepared in 100 mM PBS buﬀer pH 7.4. The
control wells were coated with 10 mg ml1 of scaﬀold or GST
receptor protein. The plate was incubated overnight at 4 C. The
samples were decanted and 250 ml of 2 casein blocking buﬀer
(Sigma Aldrich, UK) was added in each well and incubated for 2
hours at room temperature. The wells were washed 3 times
with 1 PBST (0.1% Tween in 1 PBS). Solutions containing
1 mg ml1 monoclonal anti-myc tag antibody (Abcam UK)This journal is © The Royal Society of Chemistry 2015aliquots were added to the wells and incubated for 1 hour at
room temperature before washing a further three times in 1
PBST. Wells containing immobilised receptor proteins, scaf-
fold, and GST receptor protein were incubated in 1 mg ml1 BSA
(bovine serum albumin) as control. An anti-mouse-antibody
conjugated with HRP (1 : 4000) was added as per manufactur-
er's protocol (Promega) and incubated for 1 hour at room
temperature. Aer washing ten times with 1 PBST, 1 ml of
TMB substrate solution was added and the absorbance at 650
nm was measured aer 5 minutes using a Multiskan ascent
plate reader (Thermo Fisher Scientic).
Circular dichroism (CD)
CD measurements of the puried receptor proteins and native
scaﬀold were carried out on an Applied Photophysics Chirascan
CD spectropolarimeter. 1 mg ml1 of proteins prepared in 1
PBS was used for analysis. The spectra were collected from 190
nm to 260 nm over two scans. The data were analysed using
Dichroweb analysis server35 based on the CDSSTR algorithm
calculated using the SP175 reference data sheet.36,37
Diﬀerential scanning calorimetry (DSC)
DSC measurements were carried out on a VP-DSC (Microcal)
instrument. Samples of the binders and 1 PBS buﬀer were
degassed twice under vacuum for 10 minutes. The scanning was
performed between 20 C and 110 C at a scan rate of 90C per
hour with a 15 minutes pre-scan equilibration. To establish the
reversibility of protein folding, repeated heating and cooling
was performed on the proteins. The puried binders and the
native scaﬀold were prepared at a concentration of 0.5 mg ml1
in 1 PBS at pH 7.4.
Bio-layer interferometry (BLI)
The aﬃnity and binding kinetics of receptor protein-2–anti-myc
tag antibody interaction was measured using bio-layer inter-
ferometry (BLItz, Pall Fortebio). Measurements were carried out
using the dip and read Ni-NTA biosensors. A 30 seconds
response in PBS buﬀer was rst taken to establish the baseline
of the sensor. Receptor-proteins were then immobilized on the
Ni-NTA sensor via the histidine tags of the receptor proteins by
exposing the sensor to a solution of 10 mg ml1 receptor-
proteins in PBS buﬀer for 120 seconds. Aer washing the sensor
with PBS buﬀer for 30 seconds, the sensor was then subjected to
diﬀerent concentrations of anti-myc tag antibody or BSA in PBS
buﬀer for 600 seconds to record the association phase. PBS
buﬀer was then reapplied to measure the dissociation. The
recorded association and dissociation data were corrected by
the baseline response in PBS buﬀer. A straight line was tted to
the linearised binding curve using ProFit soware (Quanso,
Switzerland).
Electrochemical impedance spectroscopy (EIS)
EIS measurements were performed using a VSP-3 electro-
chemical workstation (BioLogic science instruments, France)
and a conventional three-electrode cell that comprised a goldAnalyst, 2015, 140, 803–810 | 809
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View Article Onlineworking electrode, a Ag/AgCl saturated KCl reference elec-
trode, and a platinum wire as a counter electrode. The
measurements were taken in the frequency range 50 mHz to
100 kHz at a DC potential of 80 mV vs. reference (Ag/AgCl) by
applying a 30 mV AC potential. The working electrodes were
fabricated by evaporation of 20 nm titanium, followed by 80
nm of gold using an electron-beam evaporator (BAK 501,
Evatec AG, Switzerland).
Prior to use, the gold surface was sonicated in acetone for 5
minutes and then rinsed in ethanol. The surface was incu-
bated for 48 hours in a solution of 1 mM SH–(CH2)11–EG6–
COOH (PEG) solution prepared in 200% proof ethanol, thor-
oughly rinsed in ethanol, and then dried in nitrogen and
mounted in the cell. The PEG surface was incubated in 100
mM PB pH 7 for 10 minutes and then washed twice with 100
mM MES buﬀer, pH 5.5. The carboxyl groups of the PEG
monolayer were then activated by incubating the surface in
EDC (0.4 M)/NHS (0.1 M) for 15 minutes. EDC-NHS solution
was prepared in 100 mM MES buﬀer, pH 5.5. The surface was
incubated in 10 mg ml1 receptor protein-2 (prepared in 10
mM acetate buﬀer pH 5.5) for 1 hour, and the remaining
active EDC/NHS sites were blocked by incubating the sensor
with 1 M ethanolamine at pH 8.5 for 30 minutes. The surface
was washed twice with 100 mM PB at pH 7.
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